News

Public Drug Plan Expenditures Continue to Rise in 2016-17

September 11, 2018

Increased spending on high cost drugs and reduced savings from generics responsible for 6.3% average growth over 2 years.


Federal Minister of Health tables the 2017 Annual Report of the Patented Medicine Prices Review Board

August 22, 2018

The Honourable Ginette Petitpas Taylor, Federal Minister of Health, today tabled the 2017 Annual Report of the Patented Medicine Prices Review Board (PMPRB) with the Clerks of the House of Commons and the Senate.


High-cost specialty drugs continue to dominate the new drug landscape

June 26, 2018

The Patented Medicine Prices Review Board (PMPRB), through the National Prescription Drug Utilization Information System (NPDUIS) research initiative, today published the second annual edition of Meds Entry Watch.


New Patented Medicine Prices Review Board Chairperson announced

February 16, 2018

Dr. Mitchell Levine appointed as Chairperson of the Patented Medicine Prices Review Board


Canadian generic drug prices remain higher than international levels in recent years

February 6, 2018

The Patented Medicine Prices Review Board releases its latest report on generic drug pricing in Canada.


PAGE 1 - 2 - 3 - 4 - 5  NEXT 25  LAST 5 
Date modified: